What is BISKA?
BISKA (Blinatumomab) is an affordable and accessible cancer drug for people with a sickness called acute lymphoblastic leukemia.
We at BSK have developed a treatment that is in reach for people with acute lymphoblastic leukemia, a type of blood sickness that mostly affects young children and teenagers. This cancer is also the biggest reason for death in this group of people.
WHO is BSK?
We at BSK are a non-profit organization who believe that everyone should be easily able to access healthcare because everyone should be able to receive care with little to no effort.
President: Bethany Law
Vice-president: Susan Young
Finances: Kimia Afshar
Vision: To live in a world where everyone has equal rights and access to lifesaving medicine
Mission: To develop affordable treatment for all populations
Treatment for Acute Lymphoblastic Leukemia is currently one of the highest-costing cancer treatments in the world.
Did you know that drugs for ALL cost around $178,000 per year???
We are excited to give a cheap treatment to people with acute lymphoblastic leukemia. Our company is looking to make the cost of medications cheaper by testing the drugs in countries such as China and India. By working with these countries, we can bring new technology to them, which can help people with acute lymphoblastic leukemia in countries other than the United States. Lastly, by working with other companies and organizations, we can make the current price of acute lymphoblastic leukemia treatments lower than ever.
BSK Group can meet its goals by working with other organizations and companies such as…
- Money from the government
- Research organizations
WHEN? IT STARTS NOW.
Image Retrieved from https://gyazo.com/63ecaa48758c3d4be3151d20cb8c2937 on June 14, 2017.
Tags: acutelymphoblasticleukemia, Biska, blinatumomab, BSK, BSKGROUP, cancer, cancersociety, diagnosis, drug trials, leukemia, non-profit organization, treatment